María Inés Sosa Liprandi - Academia.edu (original) (raw)
Papers by María Inés Sosa Liprandi
Revista Argentina de Cardiología, Feb 1, 2015
Revista Argentina de Cardiología, Aug 1, 2013
Argentine Journal of Cardiology, 2015
Medicina, 1991
In order to define the coronary lesions we prospectively performed digital coronary angiographies... more In order to define the coronary lesions we prospectively performed digital coronary angiographies in 61 patients. The degree of stenosis was measured in 100 lesions by quantitative analysis using densitometric and geometric methods. Two groups of lesions were found by comparing these two methods: Group A, 47 lesions with a poor correspondence in the degree of stenosis between densitometric and geometric analysis (p greater than 0.01; and group B, 53 lesions with a good correspondence. Both groups were correlated with plaque characteristics (unstable or stable), following angiographic criteria. The mean degree of stenosis in all lesions, for densitometric and geometric analysis was 50.04 +/- 21.1% and x 60.66 +/- 22.1% (p less than 0.01), respectively. Unstable plaque was more frequent in group A (80.9%) than in B (17.9%) (p less than 0.0001), and stable plaque was more frequent in B (81.1%) than in A (19.1%) (p less than 0.0001). Less degree of stenosis between A (41.5 +/- 13.2) and...
Journal of the American College of Cardiology, 1993
Ob alias. This study was designed to compare freedom from combined cardiac events (death, mtginn,... more Ob alias. This study was designed to compare freedom from combined cardiac events (death, mtginn, myocardial Infarction) at I•, 3• said S•y ear follow-up in patients with multivessel disease randomized to either percutaneous transiwninal coronary angloo" coronary artery bypass paft surgery. Ba s gmwad. Pe+cutaneone transluminal coronary angioplasty has beer an effective approach in patients with coronary artery disease, bent its role In patients with multivesel coronary artery lease Is will controversial. Aloha. (Are-hundred twenty-seven patients with multivessel disease ad lesions suitable for either form of therapy were randomized to either coronary artery bypass grafting (a = 64) or coronary ugloplasty (n ae 63). In this study we report the Immediate results and freedom from combined cardiac events at 1-year fellow-up. Raedra. Demographic, clinical and anglographic chars rerlstics were dollar In both group. There were no differences in In-hospital deaths, frequency of periprocodure myocardial infarc-Percutaneous transluminal coronary angioplasty has been shown to be an effective therapeutic approach in patients with coronary artery disease (1,2). Its role in patients with single-vessel coronary artery disease has been well established (1,2). Coronary angioplasty has been used with increasing frequency in the treatment of patients with multivessel coronary artery disease (3-6). Although its success rate is high and the incidence of major complications is low, the efficacy of coronary angioplasty in the treatment of patients From the Cardiac Unit, Anchorena Hospital. Buenos Aires, Argentina and the "Cardiac Unit, Massachusetts General Hospital, Boston, Massachuseas, iA complete list of the ERACI Group investigators appears in the Appendix. This study was presented in put at the 41st Annual Scientific Sessions of the
Journal of Cardiac Failure, 2003
Background: Hospitalizations for heart failure (HF) are more common in blacks. However, several s... more Background: Hospitalizations for heart failure (HF) are more common in blacks. However, several studies have demonstrated better survival in black compared with white patients after a hospitalization for HF, even within an "equal access" setting of the Veterans Health Administration (VA). The reasons for this paradox of increased hospitalizations in the face of better survival are uncertain. Therefore, we examined variation by race in factors contributing to hospitalization and in severity of illness at the time of HF hospitalization, in an "equal access" setting. Methods: We reviewed medical records of 100 veterans (black ϭ 52, white ϭ 48) admitted with HF to a tertiary care VA hospital in 1999, drawn from a larger cohort of 352 veterans hospitalized for HF, that had demonstrated better survival in black patients. We evaluated differences by race in socio-demographic factors, reported behaviors (e.g., compliance with diet and medication), use of outpatient services in the previous year and clinical factors including comorbid illness and severity of illness at admission. Comorbidity was measured by a count of the number of co-morbid conditions. Severity of illness was measured with the APACHE II and EPICAL scores. The chi square test was used for comparison of categorical variables and the t-test for continuous variables. Results: There were no significant differences in age, marital status or proportion of diastolic heart failure between black and white patients. Severity of illness at admission (by APACHE and EPICAL) was also similar. However, black patients had fewer comorbid illnesses than white patients. Also, black patients had more frequent documentation of substance abuse, non-compliance with medications and social factors contributing to hospitalization and had fewer primary care visits in the year prior to hospitalization. Conclusions: Disease burden as measured by comorbid illness and severity classification was not associated with the higher likelihood of hospital admission among black compared with white patients. However, hospitalized black patients were more likely to be admitted with a history of medication noncompliance, fewer outpatient visits, uncontrolled hypertension, or other social factors. Thus black patients may experience more frequent acute illness that leads to hospitalization, but that also resolves quickly with treatment and is not associated with worse outcomes. Better survival after hospitalization for blacks with HF may be explained at least in part by hospitalization precipitated by non-clinical factors.
Rev Argent …, 2003
Antecedentes El valor pronóstico de la proteína C reactiva (PCR) en los síndromes coronarios agud... more Antecedentes El valor pronóstico de la proteína C reactiva (PCR) en los síndromes coronarios agudos sin elevación del segmento ST (SCASEST) es conocido. Existen comunicaciones que indican que el valor predictivo de la PCR desaparece con el uso previo de aspirina.
Rev. Argent. Med. …, 1996
... Mostrando: 1 .. 1 no formato [Detalhado]. página 1 de 1, 1 / 1, LILACS, seleciona. para impri... more ... Mostrando: 1 .. 1 no formato [Detalhado]. página 1 de 1, 1 / 1, LILACS, seleciona. para imprimir. Fotocópia. experimental, Documentos relacionados. Id: 205957. Autor: Baranchuk, Adrián; Intile,Dante; Darú, Víctor; Sosa Liprandi, María Inés; Sosa Liprandi, Alvaro. ...
Cardiovascular and Metabolic Science
Argentine Journal of Cardiology, Sep 3, 2017
ABC Heart Failure & Cardiomyopathy, 2021
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that occurs secondary to deposition of... more Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that occurs secondary to deposition of misfolded protein in the myocardium. The two most common subtypes are amyloid light chain amyloidosis and amyloid transthyretin amyloidosis. CA frequently results in congestive cardiac failure and arrhythmias, due to a disruption in cardiac substrate with subsequent electromechanical remodeling. Disease progression is usually demonstrated by development of progressive pump failure, which may be seen with a high arrhythmic burden, usually portending a poor prognosis. Arrhythmias are common, and many commonly used pharmacological therapies may be poorly tolerated and lead to clinical decompensation in this population, adding complexity to the co-management of these conditions. Studies are required to assess the risks and benefits of catheter ablation for ventricular tachycardia, with no current data showing a mortality benefit. The role of implantable cardioverter-defibrillator therapy is controversial, with benefits seen predominantly in early phases of the disease process. High-quality evidence and guideline recommendations are limited with regard to the management of arrhythmias. Providers are often left to clinical experience and expert consensus to aid in decision-making. This review summarizes both historical and contemporary data and describes evidence-based strategies for managing ventricular arrhythmias and their sequelae in patients with CA.
Revista Argentina de Cardiología, Oct 1, 2006
Interamerican Journal of Health Sciences, Dec 3, 2021
European Heart Journal Supplements
The purpose of this review is to update the recent information regarding the role of influenza va... more The purpose of this review is to update the recent information regarding the role of influenza vaccination (IV) as a strategy to reduce cardiovascular (CV) events. During the last 2 years, new meta-analysis, guidelines, and two randomized controlled trials (RCTs) were published. The IAMI trial added information regarding the safety and efficacy of IV right after an acute myocardial infarction hospitalization. A significant reduction in the primary endpoint—including mortality—was observed. More recently, the influenza vaccine to prevent vascular events trial (IVVE) trial did not meet the primary CV endpoint in patients with heart failure (HF). However, a significant reduction was observed during the seasonal peaks of Influenza circulation. COVID-19 pandemic provoked recruitment difficulties in these trials, as well as an altered influenza seasonality and incidence. Further analysis of IVVE trial is needed to clarify the precise role of IV in patients with HF. A recent meta-analysis ...
Current Problems in Cardiology
ABC: Heart Failure & Cardiomyopathy, 2021
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that occurs secondary to deposition of... more Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that occurs secondary to deposition of misfolded protein in the myocardium. The two most common subtypes are amyloid light chain amyloidosis and amyloid transthyretin amyloidosis. CA frequently results in congestive cardiac failure and arrhythmias, due to a disruption in cardiac substrate with subsequent electromechanical remodeling. Disease progression is usually demonstrated by development of progressive pump failure, which may be seen with a high arrhythmic burden, usually portending a poor prognosis. Arrhythmias are common, and many commonly used pharmacological therapies may be poorly tolerated and lead to clinical decompensation in this population, adding complexity to the co-management of these conditions. Studies are required to assess the risks and benefits of catheter ablation for ventricular tachycardia, with no current data showing a mortality benefit. The role of implantable cardioverter-defibrillator therapy is controversial, with benefits seen predominantly in early phases of the disease process. High-quality evidence and guideline recommendations are limited with regard to the management of arrhythmias. Providers are often left to clinical experience and expert consensus to aid in decision-making. This review summarizes both historical and contemporary data and describes evidence-based strategies for managing ventricular arrhythmias and their sequelae in patients with CA.
1 Médico cardiólogo. Jefe del Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. ... more 1 Médico cardiólogo. Jefe del Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. Director Médico. Instituto Cardiovascular Lezica. San Isidro. Buenos Aires. República Argentina. 2 Médica cardióloga. Coordinadora de Investigación Cardiovascular. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. 3 Médica cardióloga. Jefa de Cardiología del Instituto Cardiovascular Lezica. San Isidro. Buenos Aires. República Argentina. 4 Médico cardiólogo. Director del Instituto DAMIC/Fundación Rusculleda. Córdoba. República Argentina. 5 Médica cardióloga. Servicio de Cardiología. Jefa del Centro de Hipertensión Arterial del Hospital Universitario Austral (HUA). Universidad Austral. Pilar. Buenos Aires. República Argentina. 6 Médico cardiólogo. Servicio de Cardiología. Hospital Italiano de Buenos Aires. Ciudad de Buenos Aires. República Argentina. 7 Médico cardiólogo. Jefe de la Sección Hipertensión Arterial del Hospital Santojanni. GCBA. Ciudad de Buen...
Medicina, 2020
Cardiovascular diseases are the leading cause of death in most regions of the world, usually foll... more Cardiovascular diseases are the leading cause of death in most regions of the world, usually followed by infectious diseases. For decades, infections in general, and particularly those involving the respiratory system, have been known to be associated with an increased risk of cardiovascular and cerebrovascular events, and their consequent morbidity and mortality. Although vaccines are an excellent strategy in the prevention of infectious diseases, the proportion of immunized adults in our country is frankly deficient. Multiple barriers contribute to perpetuating this problem, within which the lack of prescription of the same by professionals who care for vulnerable populations occupies a central place. Patients with cardiovascular disease represent a particularly risky subpopulation. The spectrum of pathologies that can trigger respiratory infections is wide: development or worsening of heart failure, arrhythmias, acute coronary syndromes and cerebrovascular diseases, among the mai...
Background: Studies on the professional status of cardiologists in Argentina demonstrated that wo... more Background: Studies on the professional status of cardiologists in Argentina demonstrated that worse quality of life was associated with lower incomes and poorer working conditions. Knowledge of cardiologists’ present and future perceptions and expectations is necessary for the individual and proper organization of each professional, as well as for the design of public policies. Objectives: The aim of this study was to describe the present and future perceptions about the professional and economic situation of cardiologists in Argentina and analyze individual and common characteristics associated with negative perceptions. Methods: This was an observational, cross-sectional study, based on an electronically delivered survey on the demographics, working characteristics and present, in 10 years and at retirement perceptions of their professional situation, defining “Bad” or “Very bad” answers as a negative perception. Results: A total of 236 cardiologists answered the survey, 26% were...
1 Médico cardiólogo. Jefe del Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. ... more 1 Médico cardiólogo. Jefe del Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. Director Médico. Instituto Cardiovascular Lezica. San Isidro. Buenos Aires. República Argentina. 2 Médica cardióloga. Coordinadora de Investigación Cardiovascular. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. 3 Médica cardióloga. Jefa de Cardiología del Instituto Cardiovascular Lezica. San Isidro. Buenos Aires. República Argentina. 4 Médico cardiólogo. Director del Instituto DAMIC/Fundación Rusculleda. Córdoba. República Argentina. 5 Médico cardiólogo. Servicio de Cardiología. Jefe de Ecocardiografía. Policlínica Bancaria. Ciudad de Buenos Aires. República Argentina. Prof. Adjunto de Cardiología. Curso Superior de Médico Cardiólogo Universitario. Universidad del Salvador. Ciudad de Buenos Aires. Rep. Argentina. 6 Médico cardiólogo. Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. Instituto Cardiovascular Lezica...
Revista Argentina de Cardiología, Feb 1, 2015
Revista Argentina de Cardiología, Aug 1, 2013
Argentine Journal of Cardiology, 2015
Medicina, 1991
In order to define the coronary lesions we prospectively performed digital coronary angiographies... more In order to define the coronary lesions we prospectively performed digital coronary angiographies in 61 patients. The degree of stenosis was measured in 100 lesions by quantitative analysis using densitometric and geometric methods. Two groups of lesions were found by comparing these two methods: Group A, 47 lesions with a poor correspondence in the degree of stenosis between densitometric and geometric analysis (p greater than 0.01; and group B, 53 lesions with a good correspondence. Both groups were correlated with plaque characteristics (unstable or stable), following angiographic criteria. The mean degree of stenosis in all lesions, for densitometric and geometric analysis was 50.04 +/- 21.1% and x 60.66 +/- 22.1% (p less than 0.01), respectively. Unstable plaque was more frequent in group A (80.9%) than in B (17.9%) (p less than 0.0001), and stable plaque was more frequent in B (81.1%) than in A (19.1%) (p less than 0.0001). Less degree of stenosis between A (41.5 +/- 13.2) and...
Journal of the American College of Cardiology, 1993
Ob alias. This study was designed to compare freedom from combined cardiac events (death, mtginn,... more Ob alias. This study was designed to compare freedom from combined cardiac events (death, mtginn, myocardial Infarction) at I•, 3• said S•y ear follow-up in patients with multivessel disease randomized to either percutaneous transiwninal coronary angloo" coronary artery bypass paft surgery. Ba s gmwad. Pe+cutaneone transluminal coronary angioplasty has beer an effective approach in patients with coronary artery disease, bent its role In patients with multivesel coronary artery lease Is will controversial. Aloha. (Are-hundred twenty-seven patients with multivessel disease ad lesions suitable for either form of therapy were randomized to either coronary artery bypass grafting (a = 64) or coronary ugloplasty (n ae 63). In this study we report the Immediate results and freedom from combined cardiac events at 1-year fellow-up. Raedra. Demographic, clinical and anglographic chars rerlstics were dollar In both group. There were no differences in In-hospital deaths, frequency of periprocodure myocardial infarc-Percutaneous transluminal coronary angioplasty has been shown to be an effective therapeutic approach in patients with coronary artery disease (1,2). Its role in patients with single-vessel coronary artery disease has been well established (1,2). Coronary angioplasty has been used with increasing frequency in the treatment of patients with multivessel coronary artery disease (3-6). Although its success rate is high and the incidence of major complications is low, the efficacy of coronary angioplasty in the treatment of patients From the Cardiac Unit, Anchorena Hospital. Buenos Aires, Argentina and the "Cardiac Unit, Massachusetts General Hospital, Boston, Massachuseas, iA complete list of the ERACI Group investigators appears in the Appendix. This study was presented in put at the 41st Annual Scientific Sessions of the
Journal of Cardiac Failure, 2003
Background: Hospitalizations for heart failure (HF) are more common in blacks. However, several s... more Background: Hospitalizations for heart failure (HF) are more common in blacks. However, several studies have demonstrated better survival in black compared with white patients after a hospitalization for HF, even within an "equal access" setting of the Veterans Health Administration (VA). The reasons for this paradox of increased hospitalizations in the face of better survival are uncertain. Therefore, we examined variation by race in factors contributing to hospitalization and in severity of illness at the time of HF hospitalization, in an "equal access" setting. Methods: We reviewed medical records of 100 veterans (black ϭ 52, white ϭ 48) admitted with HF to a tertiary care VA hospital in 1999, drawn from a larger cohort of 352 veterans hospitalized for HF, that had demonstrated better survival in black patients. We evaluated differences by race in socio-demographic factors, reported behaviors (e.g., compliance with diet and medication), use of outpatient services in the previous year and clinical factors including comorbid illness and severity of illness at admission. Comorbidity was measured by a count of the number of co-morbid conditions. Severity of illness was measured with the APACHE II and EPICAL scores. The chi square test was used for comparison of categorical variables and the t-test for continuous variables. Results: There were no significant differences in age, marital status or proportion of diastolic heart failure between black and white patients. Severity of illness at admission (by APACHE and EPICAL) was also similar. However, black patients had fewer comorbid illnesses than white patients. Also, black patients had more frequent documentation of substance abuse, non-compliance with medications and social factors contributing to hospitalization and had fewer primary care visits in the year prior to hospitalization. Conclusions: Disease burden as measured by comorbid illness and severity classification was not associated with the higher likelihood of hospital admission among black compared with white patients. However, hospitalized black patients were more likely to be admitted with a history of medication noncompliance, fewer outpatient visits, uncontrolled hypertension, or other social factors. Thus black patients may experience more frequent acute illness that leads to hospitalization, but that also resolves quickly with treatment and is not associated with worse outcomes. Better survival after hospitalization for blacks with HF may be explained at least in part by hospitalization precipitated by non-clinical factors.
Rev Argent …, 2003
Antecedentes El valor pronóstico de la proteína C reactiva (PCR) en los síndromes coronarios agud... more Antecedentes El valor pronóstico de la proteína C reactiva (PCR) en los síndromes coronarios agudos sin elevación del segmento ST (SCASEST) es conocido. Existen comunicaciones que indican que el valor predictivo de la PCR desaparece con el uso previo de aspirina.
Rev. Argent. Med. …, 1996
... Mostrando: 1 .. 1 no formato [Detalhado]. página 1 de 1, 1 / 1, LILACS, seleciona. para impri... more ... Mostrando: 1 .. 1 no formato [Detalhado]. página 1 de 1, 1 / 1, LILACS, seleciona. para imprimir. Fotocópia. experimental, Documentos relacionados. Id: 205957. Autor: Baranchuk, Adrián; Intile,Dante; Darú, Víctor; Sosa Liprandi, María Inés; Sosa Liprandi, Alvaro. ...
Cardiovascular and Metabolic Science
Argentine Journal of Cardiology, Sep 3, 2017
ABC Heart Failure & Cardiomyopathy, 2021
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that occurs secondary to deposition of... more Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that occurs secondary to deposition of misfolded protein in the myocardium. The two most common subtypes are amyloid light chain amyloidosis and amyloid transthyretin amyloidosis. CA frequently results in congestive cardiac failure and arrhythmias, due to a disruption in cardiac substrate with subsequent electromechanical remodeling. Disease progression is usually demonstrated by development of progressive pump failure, which may be seen with a high arrhythmic burden, usually portending a poor prognosis. Arrhythmias are common, and many commonly used pharmacological therapies may be poorly tolerated and lead to clinical decompensation in this population, adding complexity to the co-management of these conditions. Studies are required to assess the risks and benefits of catheter ablation for ventricular tachycardia, with no current data showing a mortality benefit. The role of implantable cardioverter-defibrillator therapy is controversial, with benefits seen predominantly in early phases of the disease process. High-quality evidence and guideline recommendations are limited with regard to the management of arrhythmias. Providers are often left to clinical experience and expert consensus to aid in decision-making. This review summarizes both historical and contemporary data and describes evidence-based strategies for managing ventricular arrhythmias and their sequelae in patients with CA.
Revista Argentina de Cardiología, Oct 1, 2006
Interamerican Journal of Health Sciences, Dec 3, 2021
European Heart Journal Supplements
The purpose of this review is to update the recent information regarding the role of influenza va... more The purpose of this review is to update the recent information regarding the role of influenza vaccination (IV) as a strategy to reduce cardiovascular (CV) events. During the last 2 years, new meta-analysis, guidelines, and two randomized controlled trials (RCTs) were published. The IAMI trial added information regarding the safety and efficacy of IV right after an acute myocardial infarction hospitalization. A significant reduction in the primary endpoint—including mortality—was observed. More recently, the influenza vaccine to prevent vascular events trial (IVVE) trial did not meet the primary CV endpoint in patients with heart failure (HF). However, a significant reduction was observed during the seasonal peaks of Influenza circulation. COVID-19 pandemic provoked recruitment difficulties in these trials, as well as an altered influenza seasonality and incidence. Further analysis of IVVE trial is needed to clarify the precise role of IV in patients with HF. A recent meta-analysis ...
Current Problems in Cardiology
ABC: Heart Failure & Cardiomyopathy, 2021
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that occurs secondary to deposition of... more Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that occurs secondary to deposition of misfolded protein in the myocardium. The two most common subtypes are amyloid light chain amyloidosis and amyloid transthyretin amyloidosis. CA frequently results in congestive cardiac failure and arrhythmias, due to a disruption in cardiac substrate with subsequent electromechanical remodeling. Disease progression is usually demonstrated by development of progressive pump failure, which may be seen with a high arrhythmic burden, usually portending a poor prognosis. Arrhythmias are common, and many commonly used pharmacological therapies may be poorly tolerated and lead to clinical decompensation in this population, adding complexity to the co-management of these conditions. Studies are required to assess the risks and benefits of catheter ablation for ventricular tachycardia, with no current data showing a mortality benefit. The role of implantable cardioverter-defibrillator therapy is controversial, with benefits seen predominantly in early phases of the disease process. High-quality evidence and guideline recommendations are limited with regard to the management of arrhythmias. Providers are often left to clinical experience and expert consensus to aid in decision-making. This review summarizes both historical and contemporary data and describes evidence-based strategies for managing ventricular arrhythmias and their sequelae in patients with CA.
1 Médico cardiólogo. Jefe del Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. ... more 1 Médico cardiólogo. Jefe del Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. Director Médico. Instituto Cardiovascular Lezica. San Isidro. Buenos Aires. República Argentina. 2 Médica cardióloga. Coordinadora de Investigación Cardiovascular. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. 3 Médica cardióloga. Jefa de Cardiología del Instituto Cardiovascular Lezica. San Isidro. Buenos Aires. República Argentina. 4 Médico cardiólogo. Director del Instituto DAMIC/Fundación Rusculleda. Córdoba. República Argentina. 5 Médica cardióloga. Servicio de Cardiología. Jefa del Centro de Hipertensión Arterial del Hospital Universitario Austral (HUA). Universidad Austral. Pilar. Buenos Aires. República Argentina. 6 Médico cardiólogo. Servicio de Cardiología. Hospital Italiano de Buenos Aires. Ciudad de Buenos Aires. República Argentina. 7 Médico cardiólogo. Jefe de la Sección Hipertensión Arterial del Hospital Santojanni. GCBA. Ciudad de Buen...
Medicina, 2020
Cardiovascular diseases are the leading cause of death in most regions of the world, usually foll... more Cardiovascular diseases are the leading cause of death in most regions of the world, usually followed by infectious diseases. For decades, infections in general, and particularly those involving the respiratory system, have been known to be associated with an increased risk of cardiovascular and cerebrovascular events, and their consequent morbidity and mortality. Although vaccines are an excellent strategy in the prevention of infectious diseases, the proportion of immunized adults in our country is frankly deficient. Multiple barriers contribute to perpetuating this problem, within which the lack of prescription of the same by professionals who care for vulnerable populations occupies a central place. Patients with cardiovascular disease represent a particularly risky subpopulation. The spectrum of pathologies that can trigger respiratory infections is wide: development or worsening of heart failure, arrhythmias, acute coronary syndromes and cerebrovascular diseases, among the mai...
Background: Studies on the professional status of cardiologists in Argentina demonstrated that wo... more Background: Studies on the professional status of cardiologists in Argentina demonstrated that worse quality of life was associated with lower incomes and poorer working conditions. Knowledge of cardiologists’ present and future perceptions and expectations is necessary for the individual and proper organization of each professional, as well as for the design of public policies. Objectives: The aim of this study was to describe the present and future perceptions about the professional and economic situation of cardiologists in Argentina and analyze individual and common characteristics associated with negative perceptions. Methods: This was an observational, cross-sectional study, based on an electronically delivered survey on the demographics, working characteristics and present, in 10 years and at retirement perceptions of their professional situation, defining “Bad” or “Very bad” answers as a negative perception. Results: A total of 236 cardiologists answered the survey, 26% were...
1 Médico cardiólogo. Jefe del Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. ... more 1 Médico cardiólogo. Jefe del Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. Director Médico. Instituto Cardiovascular Lezica. San Isidro. Buenos Aires. República Argentina. 2 Médica cardióloga. Coordinadora de Investigación Cardiovascular. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. 3 Médica cardióloga. Jefa de Cardiología del Instituto Cardiovascular Lezica. San Isidro. Buenos Aires. República Argentina. 4 Médico cardiólogo. Director del Instituto DAMIC/Fundación Rusculleda. Córdoba. República Argentina. 5 Médico cardiólogo. Servicio de Cardiología. Jefe de Ecocardiografía. Policlínica Bancaria. Ciudad de Buenos Aires. República Argentina. Prof. Adjunto de Cardiología. Curso Superior de Médico Cardiólogo Universitario. Universidad del Salvador. Ciudad de Buenos Aires. Rep. Argentina. 6 Médico cardiólogo. Servicio de Cardiología. Sanatorio Güemes. Ciudad de Buenos Aires. República Argentina. Instituto Cardiovascular Lezica...